Stay updated with breaking news from Jacobs Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wells Fargo & Company MN trimmed its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 4.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,191,700 shares of the biopharmaceutical company’s stock after selling 337,231 shares during the quarter. Wells […]
Provident Investment Management Inc. increased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 9.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 15,338 shares of the biopharmaceutical company’s stock after purchasing an additional 1,338 shares during the quarter. Provident Investment Management […]
Compagnie Lombard Odier SCmA lifted its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 9.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,196 shares of the biopharmaceutical company’s stock after buying an additional 3,047 shares during […]
BMO Capital Markets upgraded shares of Gilead Sciences (NASDAQ:GILD – Get Rating) from a market perform rating to an outperform rating in a research report report published on Tuesday morning, The Fly reports. The firm currently has $100.00 price objective on the biopharmaceutical company’s stock, up from their prior price objective of $90.00. Other research […]
Blair William & Co. IL boosted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 7.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 519,914 shares of the biopharmaceutical company’s stock after acquiring an […]